Tigecycline as last resort in severe refractory Clostridium difficile infection: a case report

被引:10
作者
Knafl, D. [1 ]
Winhofer, Y. [2 ]
Loetsch, F. [1 ]
Weisshaar, S. [3 ]
Steininger, C. [1 ]
Burgmann, H. [1 ]
Thalhammer, F. [1 ]
机构
[1] Med Univ Vienna, Dept Med 1, Div Infect Dis & Trop Med, Vienna, Austria
[2] Med Univ Vienna, Dept Med 3, Div Endocrinol, Vienna, Austria
[3] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria
关键词
SOCIETY;
D O I
10.1016/j.jhin.2015.11.010
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:296 / 398
页数:4
相关论文
共 9 条
[1]   European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI) [J].
Bauer, M. P. ;
Kuijper, E. J. ;
van Dissel, J. T. .
CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 (12) :1067-1079
[2]  
Britt NS, 2014, INFECT DIS THER 1203
[3]   Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) [J].
Cohen, Stuart H. ;
Gerding, Dale N. ;
Johnson, Stuart ;
Kelly, Ciaran P. ;
Loo, Vivian G. ;
McDonald, L. Clifford ;
Pepin, Jacques ;
Wilcox, Mark H. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 (05) :431-455
[4]   European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection [J].
Debast, S. B. ;
Bauer, M. P. ;
Kuijper, E. J. .
CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 :1-26
[5]   Activity of tigecycline against recent European clinical isolates of Clostridium difficile [J].
Hawser, Stephen P. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 35 (01) :97-98
[6]   Intravenous Tigecycline as Adjunctive or Alternative Therapy for Severe Refractory Clostridium difficile Infection [J].
Herpers, Bjorn L. ;
Vlaminckx, Bart ;
Burkhardt, Olaf ;
Blom, Harmjo ;
Biemond-Moeniralam, Hazra S. ;
Hornef, Mathias ;
Welte, Tobias ;
Kuijper, Edward J. .
CLINICAL INFECTIOUS DISEASES, 2009, 48 (12) :1732-1735
[7]   Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea [J].
Kyne, L ;
Warny, M ;
Qamar, A ;
Kelly, CP .
LANCET, 2001, 357 (9251) :189-193
[8]   In vitro activity of tigecycline and comparators against a European compilation of anaerobes collected as part of the Tigecycline Evaluation and Surveillance Trial (TEST) [J].
Nagy, Elisabeth ;
Dowzicky, Michael J. .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2010, 42 (01) :33-38
[9]   Effect of tigecycline on normal oropharyngeal and intestinal microflora [J].
Nord, Carl Erik ;
Sillerstrom, Eva ;
Wahlund, Elisabeth .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (10) :3375-3380